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Background: Joint pain and swelling are typical symptoms in children with juvenile idiopathic arthritis (JIA) and
these are often related to inflammation of the joint. Juvenile osteochondritis dissecans (JOCD), that is separation of
a bone-cartilage segment from the articular surface, can manifest with similar symptoms.
Findings: We studied thirteen cases of osteochondritis dissecans lesions (OCD) in children with JIA. There were
nine girls and four boys with a mean age of 6.5 (2–12) years at the time of diagnosis of JIA. Mean time between
diagnosis of JIA and manifestation of OCD was 5.5 (1–11) years. Indications for MRI were the presence of pain or
discomfort in the joint, despite otherwise effective treatment, with no evidence from ultrasound examination of any
obvious signs of active inflammation. The most common location of osteochondral lesion was the knee, although
the ankle joint was affected in one case. Five patients had lesions in both knees. Operative treatment was needed
in eight cases (joints).
Conclusions: Pain, and minor dysfunction of the joint are common complaints of children suffering from JIA. Earlier
research has discounted the possibility of children who were not athletes presenting with this condition. However,
this study demonstrates that these lesions also seem to be relatively common in patients with JIA. When there is
no sign of inflammation, the possibility of OCD must therefore be considered in these children.
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Introduction
Osteochondritis dissecans (OCD) refers to the separa-
tion of a subchondral bone segment from the articular
surface. The aetiology of juvenile osteochondritis dis-
secans is not known but it is suspected that it is related
to endocrine disorders, epiphyseal or vascular abnormal-
ities, or repetitive trauma. OCD is found more frequently
in children involved in organized sports activities Symp-
toms may vary from locking or clicking to pain and swell-
ing of the joint. The natural history in children can be
self-limiting and many lesions can heal without ever being
diagnosed [1-3].
Juvenile idiopathic arthritis (JIA) is defined as arthritis
of unknown aetiology which starts before the age of 16
years and persists for more than six weeks. JIA is the
most common chronic rheumatic disease of childhood,* Correspondence: liisa.kroger@kuh.fi
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reproduction in any medium, provided the orwith a reported prevalence of between 16-150/ 100 000
in high-income countries. Juvenile arthritis is classified
according to seven different categories based on clinical
features (i.e. the number of joints inflamed), family his-
tory and laboratory markers Thus the diagnosis of JIA
consists of a heterogenous group of chronic inflamma-
tory arthritis [4]. The clinical care of children with JIA
has improved significantly over the past decade. First-line
treatment consists of nonsteroidal anti-inflammatory anal-
gesics (NSAIDs) and intra-articular steroid injections
often followed by methotrexate and, in resistant cases, by
biologic therapy [4].
Previously, conventional radiography has been the main-
stay of imaging in JIA. However, current practice is to use
ultrasound for diagnosis and Magnetic Resonance Imaging
(MRI) and ultrasound for monitoring disease activity, pro-
gression and response to treatment [5]. When trying to
determine the cause of pain and discomfort in the joints
of children with JIA, we found osteochondral lesions to be
relatively common.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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The average number of JIA patients visiting our paediat-
ric rheumatology clinic varies annually between 170 and
230. The annual number of new JIA cases varies between
15–25. During 2007–10, osteochondral lesions were found
in thirteen patients with a previous diagnosis of JIA. There
were four boys and nine girls. Twelve patients had lesions
in the knee (five of these had lesions in both knees); in
one patient the affected joint was the ankle, with the le-
sion being in the talus. Therefore the total number of af-
fected joints was 17 knees and one ankle (Table 1).
The indication for imaging was the presence of pain or
discomfort in the joint, despite otherwise effective treat-
ment for inflammation. The patients mainly complained
of pain, swelling or locking of the joint. Where ultra-
sound showed no indication of inflammation, examin-
ation was continued either with conventional plain
radiography (in eight cases) or MRI with contrast media.
In four of these eight cases the plain radiograph also
failed to demonstrate any abnormality, and examination
continued using MRI. In addition, where abnormality
was found in plain radiography or where assessment of
the activity of the disease was the main indication of im-
aging, MRI was then considered appropriate.
The mean age of patients at the time of diagnosis of
JIA was 6.5 years (range 2–12 years). Six of the patientsTable 1 Clinical characteristics of the patients with osteochon
Patient JIA type Sex, age at
diagnosis
Medication
1 Extended polyarthritis M, 4 MTX Etanercept
Infliximab Abatacept
2 Polyarthritis F, 10 MTX
3 Oligoarthritis M, 12 MTX
4 Extended Polyarthritis M, 5 MTX
5 Oligoarthritis F, 10 MTX
6 Polyarthritis M, 11 MTX
7 Oligoarthritis F, 2 MTX
8 Extended polyarthritis F, 3 MTX Oxichlorin Infliximab
Adalimumab
9 Polyarthritis F, 2 Leflunomide
10 Extended polyarthritis F, 2 MTX, SSZ Leflunomide
Etanercept Infliximab
11 Polyarthritis F, 10 MTX
12 Polyarthritis F, 9 MTX
13 Polyarthritis F, 4 MTX Leflunomide Etanercept
Abbreviations: Ia. = intra-articular, MTX = methotrexate, SSZ = sulphasalazine, M = msuffered from rheumatoid factor negative polyarthritis,
three from oligoarthritis and four were diagnosed with
extended polyarthritis (Table 1). Antinuclear antibodies
were found in three cases. Four patients reported recent
minor trauma of the joint.
All the children were under the care of paediatric
rheumatologists who supervised their drug therapy and
follow-up. All were treated with methotrexate during at
least some period of the disease. In three cases, because
of adverse effects, methotrexate was replaced by lefluno-
mide. Four patients were diagnosed with extended po-
lyarthritis; in these cases the disease was controlled not
by conventional treatment but by biologics, as is indi-
cated for this category. All four were first given TNFα
modulators (etanercept, infliximab or adalimumab); in
one case this was later replaced by abatacept (Table 1).
In addition, intra-articular glucocorticoid injections were
given where needed. The average number of intra-
articular injections given in the knee or ankle joint was
1.3 / year and the number of injections was highest in
patients who later needed biologics (Table 1). Intra-
articular injections were also given more frequently in
the early phase of the disease when inflammation was
not controlled by antirheumatic drugs. The mean time
between diagnosis of JIA and discovery of OCD lesions










10 12 Femur -
lateral




15 4 Femur lateral +
10 9 Femur lateral (l.a.) -
13 1 Femur lateral +
12 5 Femur medial and lateral l.a. -
10 2 Femur medial and lateral +
14 3 Femur medial -
11 9 Talus +
10 12 Femur medial -
14 3 Femur medial l.a. +
10 3 Femur (dx) medial and lateral -
Femur medial (sin)
15 5 Femur medial +
ale, F = female.
Kröger et al. Pediatric Rheumatology 2013, 11:18 Page 3 of 4
http://www.ped-rheum.com/content/11/1/18Five patients had osteochondral lesions in both knees,
four patients on both knees simultaneously (patients 4, 6,
11 and 12), one with an interval of three years (patient 2).
Lesions were found in the lateral condyle in nine knees
(six patients); only the medial condyle was affected in five
knees (four patients). One patient (patient 6) had lesions
in both condyles and both patellas were also affected.
There were also two sibling pairs (patients 2 and 3, patients
4 and 8).
The number of patients needing operative treatment
was 7/ 12 (58%). Indications for operative intervention
were instability of the lesion or locking of the knee.Figure 1 Radiograph and MRI showing an osteochondral lesion
of medial femoral condyle.Discussion
Osteochondritis dissecans (OCD) is a lesion of subchon-
dral bone, with or without articular cartilage involve-
ment, resulting in chondral or osteochondral fragment
separation (Figure 1). It is twice as common in males as
in females, but the true incidence of this condition in
children is not known [3,6]. In this study, there were
nine females and four males. Except in cases of enthesitis-
related arthritis, the prevalence of JIA is higher in
females [4].
The aetiology of OCD is not yet conclusively under-
stood, but trauma, ischemia and genetic factors have
been proposed [3,6]. In this small group of patients there
were two sibling pairs, suggesting a genetic cause as pre-
viously postulated [7,8]. Four patients reported minor
trauma before the appearance of symptoms.
Despite the fact that this group of patients represents
a wide range of severity of juvenile arthritis, the disease
was relatively mild in the majority of them. The goal of
treatment in JIA is to obtain total suppression of joint
inflammation, and the clinical care of children with JIA
has improved significantly in this respect over the past
decade. First-line treatment consists of NSAIDs and
intra-articular steroid injections, commonly followed by
methotrexate. An important step has been understand-
ing the mechanisms of inflammation and the develop-
ment of biologic treatment [4,9]; four patients were first
given TNFα-modulators and one later needed other
biologics.
In addition to systemic medication, these patients also
required intra-articular injections. Although the number
of injections was relatively high in some cases (eg.12 in-
jections in the same joint), these were given over a long
time span. Some patients needed injections only in the
early phase of the disease. It is possible that glucocortic-
oid injection can affect cartilage metabolism and may
even increase the risk of development of OCD [10].
However, persistent synovitis is also associated with an
increased risk of damage to cartilage and may thus in-
crease the risk of development of OCD as well [4,5].This report shows that osteochondral lesions are
frequently found in patients suffering from juvenile arth-
ritis. If the patient complains of pain , locking or swell-
ing of the knee, imaging is indicated. In some cases it is
possible to confirm or exclude the diagnosis of OCD
with a plain radiograph. However, in this study, plain
radiograph failed to show any abnormality in half of the
cases. MRI was then used either to identify or confirm
the findings. MRI may also help to evaluate the stability
of the lesion and thus give information for follow-up
and treatment [11,12]. It is possible that the routine use
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higher [12].
In the knee joint, osteochondritis dissecans is com-
monly reported to involve the medial femoral condyle
(85% of cases) and to be less common in inferolateral
(13%) or anterior lateral femoral condyle (2%) [6]. In this
study, the lateral condyle was affected in six patients,
medial in four and both in three patients. The position
of the lesions is therefore different from that shown in
previously published material.
Treatment of juvenile OCD is dependent upon the
size, location and stability of the fragment. The opti-
mal treatment of juvenile osteochondritis is not known
[13,14]. There is a possibility of spontaneous healing,
but it seems that lesions with an increased size and
mechanical symptoms are less likely to be healed spon-
taneously [13]. In this group of patients, continuous
pain, locking or intra-articular loose fragments were in-
dications for operative treatment.
Conclusion
Pain, swelling and minor dysfunction of the joint are
common complaints in children suffering from JIA.
In cases with continuous pain and discomfort and no
signs of inflammation, the possibility of OCD must be
considered.
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